Fate of graft cells: What should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?

Frontiers in Cellular Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Ikegame, Yuka ^a,b   Yamashita, Kentaro ^b,c   Nakashima, Shigeru ^b   Nomura, Yuichi ^a   Yonezawa, Shingo ^a   Asano, Yoshitaka ^a,b   Shinoda, Jun ^a,b   Hara, Hideaki ^d   Iwama, Toru ^b  

^a Department of Neurosurgery   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ASAHI UNIVERSITY   (Japan)

^d GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Ischemic stroke; Mesenchymal stem cell; Neurovascular unit; Stem cell therapy; Translational research

Indexed keywords

TECHNETIUM 99M;

ADIPOSE DERIVED STEM CELL; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL FATE; CELL KINETICS; CELL MIGRATION; DRUG ADMINISTRATION ROUTE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMMUNOHISTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; NERVE CELL; ORGANOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE GRAFT;

EID: 84908226428     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00322     Document Type: Review

References (99)

1. Abdullah, A. I., Pollock, A., and Sun, T. (2012). The path from skin to brain: generation of functional neurons from fibroblasts. Mol. Neurobiol. 45, 586-595. doi: 10.1007/s12035-012-8277-6
2. Ashjian, P. H., Elbarbary, A. S., Edmonds, B., Deugarte, D., Zhu, M., Zuk, P. A.,et al. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast. Reconstr. Surg. 111, 1922-1931. doi: 10.1097/01.PRS.0000055043.62589.05
3. Bang, O. Y., Lee, J. S., Lee, P. H., and Lee, G. (2005). Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57, 874-882. doi: 10.1002/ana.20501
4. Bhasin, A., Srivastava, M. V., Mohanty, S., Bhatia, R., Kumaran, S. S., and Bose, S. (2013). Stem cell therapy: a clinical trial of stroke. Clin. Neurol. Neurosurg. 115, 1003-1008. doi: 10.1016/j.clineuro.2012.10.015
5. Bian, S., Xu, T. L., and Sun, T. (2013). Tuning the cell fate of neurons and glia by microRNAs. Curr. Opin. Neurobiol. 23, 928-934. doi: 10.1016/j.conb.2013.08.002
6. Borlongan, C. V. (2009). Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke 40, S146-S148. doi: 10.1161/STROKEAHA.108.533091
7. Canazza, A., Minati, L., Boffano, C., Parati, E., and Binks, S. (2013). Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cell-based therapies. Front. Neurol. 5:19. doi: 10.3389/fneur.2014.00019
8. Chen, J., Li, Y., and Chopp, M. (2000). Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 39, 711-716. doi: 10.1016/S0028-3908(00)00006-X
9. Chen, J., Li, Y., Wang, L., Lu, M., Zhang, X., and Chopp, M. (2001). Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 189, 49-57. doi: 10.1002/jnr.10691
10. Cho, K. J., Trzaska, K. A., Greco, S. J., Mcardle, J., Wang, F. S., Ye, J. H.,et al. (2005). Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 23, 383-391. doi: 10.1634/stemcells.2004-0251
11. Corti, S., Nizzardo, M., Simone, C., Falcone, M., Donadoni, C., Salani, S.,et al. (2012). Direct reprogramming of human astrocytes into neural stem cells and neurons. Exp. Cell Res. 318, 1528-1541. doi: 10.1016/j.yexcr.2012.02.040
12. Coussens, L. M., Tinkle, C. L., Hanahan, D., and Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490. doi: 10.1016/s0092-8674(00)00139-2
13. Degraba, T. J., and Pettigrew, L. C. (2000). Why do neuroprotective drugs work in animals but not humans? Neurol. Clin. 18, 475-493. doi: 10.1016/S0092-8674(00)00139-2
14. Detante, O., Moisan, A., Dimastromatteo, J., Richard, M. J., Riou, L., Grillon, E.,et al. (2009). Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant. 18, 1369-1379. doi: 10.3727/096368909X474230
15. Detante, O., Valable, S., De Fraipont, F., Grillon, E., Barbier, E. L., Moisan, A.,et al. (2012). Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke. Stem Cells Transl. Med. 1, 333-341. doi: 10.5966/sctm.2011-0043
16. Doeppner, T. R., and Hermann, D. M. (2010). Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities. Stem Cells Cloning 3, 157-163. doi: 10.2147/SCCAA.S7820
17. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D.,et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317. doi: 10.1080/14653240600855905
18. Eckert, M. A., Vu, Q., Xie, K., Yu, J., Liao, W., Cramer, S. C.,et al. (2013). Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J. Cereb. Blood Flow Metab. 33, 1322-1334. doi: 10.1038/jcbfm.2013.91
19. Egashira, Y., Suzuki, Y., Azuma, Y., Takagi, T., Mishiro, K., Sugitani, S.,et al. (2013). The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J. Neuroinflammation 10, 105. doi: 10.1186/1742-2094-10-105
20. Erices, A., Conget, P., and Minguell, J. J. (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109, 235-242. doi: 10.1046/j.1365-2141.2000.01986.x
21. Feng, W., and Feng, Y. (2011). MicroRNAs in neural cell development and brain diseases. Sci. China Life Sci. 54, 1103-1112. doi: 10.1007/s11427-011-4249-8
22. Franco Lambert, A. P., Fraga Zandonai, A., Bonatto, D., Cantarelli Machado, D., and Pegas Henriques, J. A. (2009). Differentiation of human adipose-derived adult stem cells into neuronal tissue: does it work? Differentiation 77, 221-228. doi: 10.1016/j.diff.2008.10.016
23. Friedenstein, A. J., Piatetzky-Shapiro, I. I., and Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16, 381-390.
24. Ge, J., Guo, L., Wang, S., Zhang, Y., Cai, T., Zhao, R. C.,et al. (2014). The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev. 10, 295-303. doi: 10.1007/s12015-013-9492-x
25. Grande, A., Sumiyoshi, K., Lopez-Juarez, A., Howard, J., Sakthivel, B., Aronow, B.,et al. (2013). Environmental impact on direct neuronal reprogramming in vivo in the adult brain. Nat. Commun. 4, 2373. doi: 10.1038/ncomms3373
26. Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., and Shi, S. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 97, 13625-13630. doi: 10.1073/pnas.240309797
27. Guo, S., and Lo, E. H. (2009). Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke 40, S4-S7. doi: 10.1161/STROKEAHA.108.534388
28. Gutierrez-Fernandez, M., Rodriguez-Frutos, B., Ramos-Cejudo, J., Teresa Vallejo-Cremades, M., Fuentes, B., Cerdan, S.,et al. (2013). Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res. Ther. 4, 11. doi: 10.1186/scrt159
29. Guzman, R., Choi, R., Gera, A., De Los Angeles, A., Andres, R. H., and Steinberg, G. K. (2008). Intravascular cell replacement therapy for stroke. Neurosurg. Focus 24, E15. doi: 10.3171/FOC/2008/24/3-4/E14
30. Hao, L., Zou, Z., Tian, H., Zhang, Y., Zhou, H., and Liu, L. (2014). Stem cell-based therapies for ischemic stroke. Biomed. Res. Int. 2014, 468748. doi: 10.1155/2014/468748
31. Hess, D. C., Hill, W. D., Martin-Studdard, A., Carroll, J., Brailer, J., and Carothers, J. (2002). Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 33, 1362-1368. doi: 10.1161/01.STR.0000014925.09415.C3
32. Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R.,et al. (2011). Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134, 1790-1807. doi: 10.1093/brain/awr063
33. Honmou, O., Onodera, R., Sasaki, M., Waxman, S. G., and Kocsis, J. D. (2012). Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol. Med. 18, 292-297. doi: 10.1016/j.molmed.2012.02.003
34. Hoyte, L., Barber, P. A., Buchan, A. M., and Hill, M. D. (2004). The rise and fall of NMDA antagonists for ischemic stroke. Curr. Mol. Med. 4, 131-136. doi: 10.2174/1566524043479248
35. Hsiao, S. T., Asgari, A., Lokmic, Z., Sinclair, R., Dusting, G. J., Lim, S. Y.,et al. (2012). Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev. 21, 2189-2203. doi: 10.1089/scd.2011.0674
36. Ikegame, Y., Yamashita, K., Hayashi, S., Mizuno, H., Tawada, M., You, F.,et al. (2011). Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13, 675-685. doi: 10.3109/14653249.2010.549122
37. Ishizaka, S., Horie, N., Satoh, K., Fukuda, Y., Nishida, N., and Nagata, I. (2013). Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke 44, 720-726. doi: 10.1161/STROKEAHA.112.677328
38. Jiang, W., Liang, G., Li, X., Li, Z., Gao, X., Feng, S.,et al. (2014). Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAo. J. Mater. Sci. Mater. Med. 25, 1357-1366. doi: 10.1007/s10856-014-5157-9
39. Jung, Y., Bauer, G., and Nolta, J. A. (2012). Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30, 42-47. doi: 10.1002/stem.727
40. Kalladka, D., and Muir, K. W. (2014). Brain repair: cell therapy in stroke. Stem Cells Cloning 7, 31-44. doi: 10.2147/SCCAA.S38003
41. Kang, S. G., Shinojima, N., Hossain, A., Gumin, J., Yong, R. L., Colman, H.,et al. (2010). Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery 67, 711-720. doi: 10.1227/01.NEU.0000377859.06219.78
42. Kern, S., Eichler, H., Stoeve, J., Klueter, H., and Bieback, K. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301. doi: 10.1634/stemcells.2005-0342
43. Kim, J., Ambasudhan, R., and Ding, S. (2012). Direct lineage reprogramming to neural cells. Curr. Opin. Neurobiol 22, 778-784. doi: 10.1016/j.conb.2012.05.001
44. Kim, S. J., Moon, G. J., Chang, W. H., Kim, Y. H., and Bang, O. Y. (2013). Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial. Trials 14, 317. doi: 10.1186/1745-6215-14-317
45. Kubis, N., Tomita, Y., Tran-Dinh, A., Planat-Benard, V., Andre, M., Karaszewski, B.,et al. (2007). Vascular fate of adipose tissue-derived adult stromal cells in the ischemic murine brain: a combined imaging-histological study. Neuroimage 34, 1-11. doi: 10.1016/j.neuroimage.2006.09.014
46. Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Ishii, K., Kobune, M.,et al. (2005). Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol. Ther. 11, 96-104. doi: 10.1016/j.ymthe.2004.09.020
47. Lalu, M. M., Mcintyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall, J. C.,et al. (2012). Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS ONE 7:e47559. doi: 10.1371/journal.pone.0047559
48. Lancaster, M. A., Renner, M., Martin, C. A., Wenzel, D., Bicknell, L. S., Hurles, M. E.,et al. (2013). Cerebral organoids model human brain development and microcephaly. Nature 501, 373-379. doi: 10.1038/nature12517
49. Lee, J. S., Hong, J. M., Moon, G. J., Lee, P. H., Ahn, Y. H., and Bang, O. Y. (2010). A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28, 1099-1106. doi: 10.1002/stem.430
50. Leu, S., Lin, Y. C., Yuen, C. M., Yen, C. H., Kao, Y. H., Sun, C. K.,et al. (2010). Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J. Transl. Med. 8, 63. doi: 10.1186/1479-5876-8-63
51. Li, H., Fan, X., Kovi, R. C., Jo, Y., Moquin, B., Konz, R.,et al. (2007). Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res. 67, 10889-10898. doi: 10.1158/0008-5472.can-07-2665
52. Li, Y., Chen, J., Zhang, C. L., Wang, L., Lu, D., Katakowski, M.,et al. (2005). Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49, 407-417. doi: 10.1002/glia.20126
53. Li, Y., Chopp, M., Chen, J., Wang, L., Gautam, S. C., Xu, Y.-X.,et al. (2000). Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J. Cereb. Blood Flow Metab. 20, 1311-1319. doi: 10.1097/00004647-200009000-00006
54. Liu, L., Eckert, M. A., Riazifar, H., Kang, D. K., Agalliu, D., and Zhao, W. (2013). From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int. 2013, 435093. doi: 10.1155/2013/435093
55. Locatelli, F., Bersano, A., Ballabio, E., Lanfranconi, S., Papadimitriou, D., Strazzer, S.,et al. (2009). Stem cell therapy in stroke. Cell. Mol. Life Sci. 66, 757-772. doi: 10.1007/s00018-008-8346-1
56. Lujan, E., and Wernig, M. (2012). The many roads to Rome: induction of neural precursor cells from fibroblasts. Curr. Opin. Genet. Dev. 22, 517-522. doi: 10.1016/j.gde.2012.07.002
57. Mahmood, A., Wu, H., Qu, C., Xiong, Y., and Chopp, M. (2013). Effects of treating traumatic brain injury with collagen scaffolds and human bone marrow stromal cells on sprouting of corticospinal tract axons into the denervated side of the spinal cord. J. Neurosurg. 118, 381-389. doi: 10.3171/2012.11.JNS12753
58. Maltman, D. J., Hardy, S. A., and Przyborski, S. A. (2011). Role of mesenchymal stem cells in neurogenesis and nervous system repair. Neurochem. Int. 59, 347-356. doi: 10.1016/j.neuint.2011.06.008
59. Meng, X., Su, R. J., Baylink, D. J., Neises, A., Kiroyan, J. B., Lee, W. Y.,et al. (2013). Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor. Cell Res. 23, 658-672. doi: 10.1038/cr.2013.40
60. Mitkari, B., Kerkela, E., Nystedt, J., Korhonen, M., Mikkonen, V., Huhtala, T.,et al. (2013). Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Exp. Neurol. 239, 158-162. doi: 10.1016/j.expneurol.2012.09.018
61. Miyamoto, M., Kuroda, S., Zhao, S., Magota, K., Shichinohe, H., Houkin, K.,et al. (2013). Bone marrow stromal cell transplantation enhances recovery of local glucose metabolism after cerebral infarction in rats: a serial 18F-FDG PET study. J. Nucl. Med. 54, 145-150. doi: 10.2967/jnumed.112.109017
62. Namihira, M., and Nakashima, K. (2011). "Fate specification of neural stem cells," in Neurogenesis in the Adult Brain I, eds T. Seki, K. Sawamoto, J. M. Parent, and A. Alvarez-Buylla (Tokyo: Springer Japan), 87-107. doi: 10.1007/978-4-431-53933-9_3
63. Orito, K., Harada, H., Hara, M., Yamashita, S., Kikuchi, K., and Shigemori, M. (2010). Cerebrospinal fluid following cerebral ischemia accelerates the proliferation of bone marrow stromal cells in vitro. Kurume Med. J. 57, 21-28. doi: 10.2739/kurumemedj.57.21
64. Paul, G., Ozen, I., Christophersen, N. S., Reinbothe, T., Bengzon, J., Visse, E.,et al. (2012). The adult human brain harbors multipotent perivascular mesenchymal stem cells. PLoS ONE 7:e35577. doi: 10.1371/journal.pone.0035577
65. Pham, J. T., and Gallicano, G. I. (2012). Specification of neural cell fate and regulation of neural stem cell proliferation by microRNAs. Am. J. Stem Cells 1, 182-195.
66. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D.,et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. doi: 10.1126/science.284.5411.143
67. Planat-Benard, V., Silvestre, J. S., Cousin, B., Andre, M., Nibbelink, M., Tamarat, R.,et al. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109, 656-663. doi: 10.1161/01.CIR.0000114522.38265.61
68. Renfranz, P. J., Cunningham, M. G., and Mckay, R. D. (1991). Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66, 713-729. doi: 10.1016/0092-8674(91)90116-G
69. Rosado-De-Castro, P. H., Pimentel-Coelho, P. M., Da Fonseca, L. M., De Freitas, G. R., and Mendez-Otero, R. (2013a). The rise of cell therapy trials for stroke: review of published and registered studies. Stem Cells Dev. 22, 2095-2111. doi: 10.1089/scd.2013.0089
70. Rosado-De-Castro, P. H., Schmidt Fda, R., Battistella, V., Lopes De Souza, S. A., Gutfilen, B., Goldenberg, R. C.,et al. (2013b). Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regen. Med. 8, 145-155. doi: 10.2217/rme.13.2
71. Safford, K. M., and Rice, H. E. (2005). Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived stem cells. Curr. Drug Targets 6, 57-62. doi: 10.2174/1389450053345028
72. Saito, H., Magota, K., Zhao, S., Kubo, N., Kuge, Y., Shichinohe, H.,et al. (2013).-123I-iomazenil single photon emission computed tomography visualizes recovery of neuronal integrity by bone marrow stromal cell therapy in rat infarct brain. Stroke 44, 2869-2874. doi: 10.1161/STROKEAHA.113.001612
73. Savitz, S. I., Chopp, M., Deans, R., Carmichael, T., Phinney, D., and Wechsler, L. (2011). Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke 42, 825-829. doi: 10.1161/STROKEAHA.110.601914
74. Shen, L. H., Li, Y., Chen, J., Zhang, J., Vanguri, P., Borneman, J.,et al. (2006). Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 137, 393-399. doi: 10.1016/j.neuroscience.2005.08.092
75. Shi, Z., and Jiao, J. (2012). Direct lineage conversion: induced neuronal cells and induced neural stem cells. Protein Cell 3, 826-833. doi: 10.1007/s13238-012-2068-8
76. Snyder, E. Y., Deitcher, D. L., Walsh, C., Arnold-Aldea, S., Hartwieg, E. A., and Cepko, C. L. (1992). Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68, 33-51. doi: 10.1016/0092-8674(92)90204-P
77. Steiner, B., Roch, M., Holtkamp, N., and Kurtz, A. (2012). Systemically administered human bone marrow-derived mesenchymal stem home into peripheral organs but do not induce neuroprotective effects in the MCAo-mouse model for cerebral ischemia. Neurosci. Lett. 513, 25-30. doi: 10.1016/j.neulet.2012.01.078
78. Suzuki, J., Sasaki, M., Harada, K., Bando, M., Kataoka, Y., Onodera, R.,et al. (2013). Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model. Brain Res. 1497, 15-22. doi: 10.1016/j.brainres.2012.12.028
79. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. doi: 10.1016/j.cell.2006.07.024
80. Teng, H., Zhang, Z. G., Wang, L., Zhang, R. L., Zhang, L., Morris, D.,et al. (2008). Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J. Cereb. Blood Flow Metab. 28, 764-771. doi: 10.1038/sj.jcbfm.9600573
81. Terada, N., Hamazaki, T., Oka, M., Hoki, M., Mastalerz, D. M., Nakano, Y.,et al. (2002). Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545. doi: 10.1038/nature730
82. The STEPS Participants. (2009). Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 40, 510-515. doi: 10.1161/STROKEAHA.108.526863
83. Ukai, R., Honmou, O., Harada, K., Houkin, K., Hamada, H., and Kocsis, J. D. (2007). Mesenchymal stem cells derived from peripheral blood protects against ischemia. J. Neurotrauma 24, 508-520. doi: 10.1089/neu.2006.0161
84. Vasconcelos-Dos-Santos, A., Rosado-De-Castro, P. H., Lopes De Souza, S. A., Da Costa Silva, J., Ramos, A. B., Rodriguez De Freitas, G.,et al. (2012). Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: is there a difference in biodistribution and efficacy? Stem Cell Res. 9, 1-8. doi: 10.1016/j.scr.2012.02.002
85. Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Sudhof, T. C., and Wernig, M. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041. doi: 10.1038/nature08797
86. Wan, H., Li, F., Zhu, L., Wang, J., Yang, Z., and Pan, Y. (2013). Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke. J. Mol. Neurosci. 52, 177-185. doi: 10.1007/s12031-013-0119-0
87. Wei, L., Fraser, J. L., Lu, Z. Y., Hu, X., and Yu, S. P. (2012). Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol. Dis. 46, 635-645. doi: 10.1016/j.nbd.2012.03.002
88. Wislet-Gendebien, S., Bruyère, F., Hans, G., Leprince, P., Moonen, G., and Rogister, B. (2004). Nestin-positive mesenchymal stem cells favour the astroglial lineage in neural progenitors and stem cells by releasing active BMP4. BMC Neurosci. 5:33. doi: 10.1186/1471-2202-5-33
89. Wislet-Gendebien, S., Hans, G., Leprince, P., Rigo, J. M., Moonen, G., and Rogister, B. (2005). Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells 23, 392-402. doi: 10.1634/stemcells.2004-0149
90. Wrage, P. C., Tran, T., To, K., Keefer, E. W., Ruhn, K. A., Hong, J.,et al. (2008). The neuro-glial properties of adipose-derived adult stromal (ADAS) cells are not regulated by Notch 1 and are not derived from neural crest lineage. PLoS ONE 3:e1453. doi: 10.1371/journal.pone.0001453
91. Xin, H., Li, Y., Cui, Y., Yang, J. J., Zhang, Z. G., and Chopp, M. (2013). Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cereb. Blood Flow Metab. 33, 1711-1715. doi: 10.1038/jcbfm.2013.152
92. Yang, N., Ng, Y. H., Pang, Z. P., Sudhof, T. C., and Wernig, M. (2011). Induced neuronal cells: how to make and define a neuron. Cell Stem Cell 9, 517-525. doi: 10.1016/j.stem.2011.11.015
93. Yang, N., Zuchero, J. B., Ahlenius, H., Marro, S., Ng, Y. H., Vierbuchen, T.,et al. (2013). Generation of oligodendroglial cells by direct lineage conversion. Nat. Biotechnol. 31, 434-439. doi: 10.1038/nbt.2564
94. Yavagal, D. R., Lin, B., Raval, A. P., Garza, P. S., Dong, C., Zhao, W.,et al. (2014). Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. PLoS ONE 9:e93735. doi: 10.1371/journal.pone.0093735
95. Yu, J. M., Bunnell, B. A., and Kang, S. K. (2011). Neural differentiation of human adipose tissue-derived stem cells. Methods Mol. Biol. 702, 219-231. doi: 10.1007/978-1-61737-960-4_16
96. Yu, Z., Wu, S., Liu, Z., Lin, H., Chen, L., Yuan, X.,et al. (2014). Sonic hedgehog and retinoic acid induce bone marrow-derived stem cells to differentiate into glutamatergic neural cells. J. Immunoassay Immunochem. 36, 1-15. doi: 10.1080/15321819.2014.889025
97. Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C.,et al. (2000). VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838. doi: 10.1172/jci9369
98. Zuk, P. (2013). Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells 2013, 35. doi: 10.1155/2013/713959
99. Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H.,et al. (2002). Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279-4295. doi: 10.1091/mbc.E02-02-0105